Subscribe To
VTYX / Ventyx Biosciences Stock Flals Over 4%: Details
VTYX News
By Zacks Investment Research
October 11, 2023
Ventyx (VTYX) Down Despite Positive Ulcerative Colitis Study Data
Ventyx Biosciences (VTYX) announces positive top-line data from a phase II study evaluating its pipeline candidate, VTX002, for treating moderate-to-s more_horizontal
By The Motley Fool
October 10, 2023
Why Shares of Ventyx Biosciences Are Dropping Tuesday
Ventyx is a clinical-stage biotech that focuses on autoimmune disorders. The company's lead therapy candidate is VTX002 to treat moderate-to-severe ul more_horizontal
By Seeking Alpha
August 13, 2023
Ventyx Biosciences, Inc. (VTYX) Q2 2023 Earnings Call Transcript
Start Time: 16:30 January 1, 0000 5:23 PM ET Ventyx Biosciences, Inc. (NASDAQ:VTYX ) Q2 2023 Earnings Conference Call August 10, 2023, 16:30 PM ET Com more_horizontal
By The Motley Fool
July 3, 2023
Why Shares of Ventyx Biosciences Rose Monday
Ventyx's shares shot up while insiders were selling. The company is a clinical-stage biotech. more_horizontal
By Seeking Alpha
June 15, 2023
Ventyx: Critical Proof Of Concept Data Later This Year
Ventyx Biosciences, Inc. has a number of interesting assets in mid-stage trials. The company is founded by a successful serial entrepreneur. Phase 2 d more_horizontal
By Seeking Alpha
May 14, 2023
Ventyx Biosciences, Inc. (VTYX) Q1 2023 Earnings Call Transcript
Ventyx Biosciences, Inc. (NASDAQ:VTYX ) Q1 2023 Earnings Conference Call May 11, 2023 6:00 PM ET Company Participants Raju Mohan - Founder & Chief Exe more_horizontal
By Pulse2
March 24, 2023
Ventyx Biosciences Stock Flals Over 4%: Details
The stock price of Ventyx Biosciences Inc (NASDAQ: VTYX) fell by over 4% intraday today. This is why. more_horizontal
By Seeking Alpha
March 23, 2023
Ventyx Biosciences, Inc. (VTYX) Q4 2022 Earnings Call Transcript
Ventyx Biosciences, Inc. (NASDAQ:VTYX ) Q4 2022 Earnings Conference Call March 24, 2023 4:30 PM ET Company Participants Raju Mohan - Founder & Chief E more_horizontal